-
Tinker Bell Express has received hundreds of millions of dollars in financing from SoftBank China Pharmaceutical O2O to usher in a new retail wind
Time of Update: 2021-02-19
Yang Wenlong revealed that Tinker Bell Express will further improve the FSC alliance, enrich the drug type, build a chain of pharmacies O2O new industry, through the construction of a direct pharmacy system, integration of online and offline resources.
-
New hope has been expressed for patients with ALK-positive non-small cell lung cancer
Time of Update: 2021-01-23
Crizotinib Xalkori, a competitive multi-target protein kinase inhibitor developed by Pfizer to inhibit Met, ALK, and ROS, was approved by the FDA for the treatment of ALK-positive late/metastasis NSCLC (2011/08) and ROS1-positive late/metastasis NSCLC (2016/03).
-
Tianjin Industrial and Social University has made progress in building a food safety protein expression system to prepare scarce sugars
Time of Update: 2021-01-20
The functional sugar and natural active substances research team led by Sun Weixia, a researcher at the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences, used the food-grade Glutamate Lollipop as the starting strain, and constructed the production strain using the combination expression strategy of isoenzyme, and the glycoenzyme vitality obtained increased about 20 times.
-
MsD anti-infection new drug of "Pharmaceutical Express" has been approved clinically in China for listing trilaciclib
Time of Update: 2021-01-19
November 18, 2020 / Medical Information List: Mercadon anti-infection new drugs declared on the market in China; Roche reached a 260 million euro research and development cooperation; No. nor Nord announced the main results of phase 3b clinical trials of Somalutide; Synractic Pharmaceuticals Trilaciclib was approved clinically; ...
-
Eya2 has been expressed in human prostate cancer and regulates polyene yew alcohol sensitivity
Time of Update: 2020-12-29
In addition, data from the Oncomine database showed elevated levels of EYA2 mRNA expression in prostate cancer tissue compared to normal tissues.
Therefore, data from the TCGA prostate queue show that EYA2 mRNA is positively related to the expression of Bcl-2 and MMP7.
-
The Lilly COVID-19 antibody trial of the "Pharmaceutical Express" has suspended Theotai's application for listing.
Time of Update: 2020-10-22
October 14, 2020 / Medical Information List: Lilly COVID-19 antibody trial suspended; Baeotelli's third product filed for market; AstraZeneta/13 weight ADC therapy submitted another clinical trial application in China; Johnson and Johnson 2020Q3 sales of $21.1 billion ...
-
After NMN, Harvard has found that gene expression or decision-d'a-half-live, the era of longevity is coming?
Time of Update: 2020-10-20
In 2016, Professor David Sinclair began experimenting with a generation of raw materials from Serifon NMN, and in 2018 published a paper in cell, a leading scientific journal, on the ability of NAD plus to reverse vascular aging.
-
Pfizer, the Pharmaceutical Express, has invested $200 million in Keystone Pharmaceuticals.
Time of Update: 2020-10-16
September 30, 2020 / Medical Information List: 100% of such clinics are spot-checked; Ironwood suspends research and development of GERD drugs and lays off 100 people; Myovant publishes clinical failure data for Stage 3 of Relugolix prostate cancer; regeneratives: preliminary clinical results of new coronary and antibody therapy ...
-
The second wave is coming? Express: China has many new overseas imports of new crown infection
Time of Update: 2020-10-03
Qingdao a company found 2 cases of asymptomatic infection on September 24, 2020, Qingdao City in Qingdao Port Dagang company "due diligence" personnel regular routine testing, has found that 2 loading
-
A group of 6.2 billion people from Pharmaceutical Express has acquired four pharmaceutical
Time of Update: 2020-09-09
(Pharmaceutical Rubik's Cube) Xi'an Yangsen Apatamine was approved in China the 2nd indications of drug approval documents issued by the State Drug Administration to receive the announcement shows that Xi'an Yangsen's new generation of androgen inhibitor apatamine tablets in the country's second indications market application has been officially approved.
-
The expression of genetically modified cotton that blocks the synthesis of cotton bellworm hormone dsRNA has been successfully cultivated.
Time of Update: 2020-09-08
zhu Wei research team of the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, through the screening of a large number of RNAi targets, finally determined the key base for controlling the metabolism of insect child-keeping hormones because of the best targets.
-
The Chinese Academy of Sciences has interpreted the "programming language" that directs gene
Time of Update: 2020-08-11
researchers in the study determined that the transposon is an important cause of human evolution, is that it is mainly in the embryo active state, so that the human genome produces new mutations.
-
The California Institute of Technology has developed ultrasound imaging systems that enable people to see gene expression for themselves.
Time of Update: 2020-08-05
, the protein structure requires the involvement of many different genes, which are also not simple to move to mammalian cells at the same time.
in the "hollow protein structure" group, ultrasound imaging clearly showed that only the outermost layer of the tumor had the expression of the reported gene.
-
The prefrontal cortex has conscious and unconscious responses to social/emotional facial
Time of Update: 2020-07-27
!---- passively viewing emotionally stimulating images can promote attention-oriented and activate neural circuits the subcutaneous and cerebral cortex pathways in the "social brain" network of indiv
-
Express . . . Keytruda has been approved by the FDA for a first-line single drug for specific
Time of Update: 2020-07-18
▎ the US FDA announced today that it has approved the extended indication of keytruda (pembrolizumab), a heavy-weight PD-1 inhibitor developed by MSD, as the first-line treatment for colorectal cancer patients with unresectable or metastatic microsatellite instability (MSI-H) or mismatch repair defect (dmmr).